Skip to content

The effect of psychologically informed physiotherapy on patients with migraine - a multicenter randomized controlled trial.

The effect of psychologically informed physiotherapy on patients with migraine - a multicenter randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024126
Enrollment
112
Registered
2021-01-25
Start date
2021-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43

Interventions

Group 1: Psychologically informed physiotherapy (Combination of physical therapy techniques, education and behavioral interventions, and strategies to improve adherence) Group 2: Progressive muscle re

Sponsors

Migräne- und Kopfschmerzklinik Königstein i.T.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Men and women with episodic or chronic migraine (= 4 migraine days per 4 weeks, diagnosis of migraine according to ICHD-3 by a neurologist) - At least one headache-free day per 4 weeks - = 18 years of age - no or stable medication prophylaxis for > 2 months - No regular use of relaxation techniques to date

Exclusion criteria

Exclusion criteria: - rehab with focus on headache therapy or multimodal pain therapy in the past six months - current use of physiotherapy/osteopathy/massage therapy or psychotherapy - Additional secondary headache disorder - Fibromyalgia syndrome - Lack of German language skills to fill in the questionnaires - Not in possession of an internet-enabled computer or smartphone to fill out the questionnaires and the online headache calendar

Design outcomes

Primary

MeasureTime frame
what: migraine headache days per month, when: baseline, post-treatment, 6 months follow-up, how: online headache diary

Secondary

MeasureTime frame
what: headache intensity, headache duration, headache impact on ability to function, quality of life, selfefficacy, medication intake, depression, anxiety and stress, when: baseline, post-treatment, 6 months follow-up, how: online questionnaires

Countries

Germany

Contacts

Public ContactBenjamin Schäfer

Migräne- und Kopfschmerzklinik

migraenestudie@posteo.de0617429040

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026